Thales Helps Microsoft Customers Protect Their Sensitive Data in the Cloud
16.3.2021 12:00:00 EET | Business Wire | Press release
Thales announces a new data protection capability for Microsoft customers to benefit from the power of the full range of Microsoft 365 applications while protecting sensitive data in the cloud and meeting major data privacy regulations and requirements.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005009/en/
Copyright Thales
Designed for companies that operate in highly-regulated sectors such as financial services and healthcare, they can now leverage Thales Luna Hardware Security Modules (HSMs) with Double Key Encryption for Microsoft 365 and comply with regulations such as the EU General Data Protection Regulation (GDPR), the Health Insurance Portability and Accountability Act (HIPAA), and the recommendations from the European Data Protection Board (EDPR) following the Schrems II ruling.
Securing Data in the Era of Remote Working and Increased Privacy Regulations
Today’s remote working environment relies heavily on the collaborative sharing of information, challenging organisations to maintain the security of confidential data and regulatory compliance while driving employee productivity. For organisations in highly regulated industries such as financial services, governments, and healthcare, their sensitive data requires the highest level of control and security. The integration of Luna HSMs with Double Key Encryption for Microsoft 365 delivers the protection required to protect highly sensitive data and meet unique regulatory requirements.
“The premise of remote working is no longer a perk reserved for a select few, but now the default operating model for many companies,” said Imran Mohiuddin, DKE partner director at Microsoft. “Our collaboration and productivity tools for Microsoft 365 customers are designed to enable companies to thrive in any situation. A key part in enabling this to happen though is ensuring they have the best security and compliance solutions when it comes to protecting sensitive data. Our Double Key Encryption integration with Thales enables customers who have enhanced data protection requirements, compliance obligations and regulatory restrictions to protect their highly sensitive information. By having full control of their encryption keys, customers can be certain that no third-party has access to their unencrypted data -- including Microsoft. Security should never be something that holds companies back in this remote era and from moving their sensitive information to the cloud, and with Thales, we’re ensuring it won’t for our customers.”
Thales has integrated its industry-leading Luna HSMs with Microsoft Double Key Encryption for Microsoft 365. This allows customers to protect their most confidential or sensitive data while maintaining control of their encryption keys in the cloud. The solution works by using two keys to protect data. One key is managed securely by the customer via the Luna HSM and a second key in Microsoft’s control. To view the data, one must have access to both keys, meaning it can’t be used without the customer’s permission.
“Our collaboration with Microsoft is designed to give peace of mind to customers when it comes to security, no matter where or what Microsoft applications they’re accessing,” said Todd Moore, vice president of encryption solutions at Thales. “The way we work has changed forever and in order to thrive, businesses have had to increasingly adapt and adopt collaborative applications. The integration of Thales Luna HSMs with Microsoft Double Key Encryption provides businesses with control over their encrypted data, in line with regulatory requirements, regardless of their industry.”
|
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions. Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
|
PLEASE VISIT
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005009/en/
Contact information
PRESS
Thales, Media Relations
Market
Laura Bandiera
+33 (0)7 64 48 51 64
laura.bandiera@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hologic Signs Definitive Agreement to Acquire Reveal Genomics19.10.2026 22:30:00 EEST | Press release
Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test to help optimize therapy for patients with HER2-positive breast cancer. Breast cancer remains one of the most significant health challenges women face today. Reveal Genomics’ tests are highly complementary to Hologic’s existing oncology diagnostics, including the Breast Cancer Index® (BCI) test, the guideline-recognized genomic assay to help inform decisions regarding extended endocrine therapy in women with HR+ early-stage breast cancer. The combination of Hologic’s existing testing with Reveal Genomics’ portfolio represents a significant expansion of Hologic’s diagnostic oncology solutions, with the combined offering of new and existing testing expected to help inform treatment decisions fo
An Active Role in Freshness: ProAmpac Introduces ProActive Intelligence Shelf Protect19.10.2026 22:27:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, introduces ProActive Intelligence™ Shelf Protect (SP) Series, giving food producers a new way to help preserve product quality and reduce costly spoilage. Designed for select meat, seafood, and dairy applications, the technology is FDA- and USDA-compliant for intended uses in fresh beef, fresh pork, cooked sausage, deli meat, fresh salmon, and fresh cheese. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261019305953/en/ Clearshield®-SP Shrink Bag This direct food-contact biotechnology packaging helps reduce microbial growth associated with food spoilage in intended applications, supporting longer shelf life throughout storage and distribution. Shelf Protect’s patented biotechnology is built directly into food-contact packaging film. “For meat processors, every product lost represents an investment in production, packaging, and distribution that goes unreal
Vedanta Ltd Doubles Zinc Capacity in South Africa with US$ 600 Mn investment19.10.2026 20:19:00 EEST | Press release
Vedanta Limited doubled its annual zinc production capacity to 500,000 tonnes1in South Africa through an investment of nearly US$ 600 Mn at Gamsberg (Phase II) at Vedanta Zinc International (VZI). Gamsberg has one of the world’s most significant zinc deposits and is VZI’s flagship zinc mine. Inaugurated by South African President Cyril Ramaphosa and Vedanta Limited Director Priya Agarwal-Hebbar, this expansion marks one of the decade’s largest mining investments in South Africa. It advances Vedanta Limited’s position as the world’s largest2 zinc producer, with a vision of achieving 3 million tonnes of annual production across India and South Africa. Of this, 2 million tonnes are targeted from its subsidiary, Hindustan Zinc Limited the world’s largest integrated zinc producer, while Vedanta Zinc International business aims to contribute 1 million tonnes annually. This expansion strengthens the ZAR 21 Bn (nearly US$ 1.5 Bn) investment commitment Vedanta made at the 2018 South Africa Inve
Unlocking Digital Gold’s US$700bn Opportunity19.10.2026 19:00:00 EEST | Press release
The digital gold market, worth US$45–55bn today, could unlock up to US$700bn in latent demand, according to new research from World Gold Council and Boston Consulting Group. The report points to substantial untapped appetite among retail investors, with nearly nine in ten surveyed saying they would consider digital gold under the right conditions. The US$700bn opportunity represents the report’s estimate of total latent demand that could be released if today’s barriers to adoption were removed, rather than a near-term forecast. The report’s five-year base case sees digital gold growing by around 27% a year to US$160–170bn by 2031. That could rise to US$270–280bn over the same time if more barriers fall faster. Momentum is already building as financial markets undergo a broader digital transformation, bringing tokenised investment products increasingly into the mainstream. Tokenised gold, one segment of the digital gold market alongside vaulted digital gold, has grown fivefold in value
Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 202619.10.2026 17:00:00 EEST | Press release
Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place October 26-28 in New Orleans, Louisiana, USA. At Booth 1100 in the exhibit hall, Roquette’s Health & Pharma Solutions team will share their expertise across controlled-release technologies, hydroxypropyl beta-cyclodextrins, and sustainable formulation approaches, alongside a comprehensive portfolio of innovative solutions designed to address the evolving needs of pharmaceutical developers. “AAPS PharmSci 360 is a key opportunity to share our latest innovations, as well as highlight the breadth and depth of our scientific know-how that helps our customers solve complex formulation challenges,” said Peter Freed, Head of Technical Service & Development North America for Roquette’s Health & Pharma Solutions Business Unit. “From a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
